Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tralokinumab

EU orphan designation number: EU/3/12/1061   
Active ingredient: Tralokinumab
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: MedImmune Ltd
Milstein Building, Granta Park, Great Abington, Cambridgeshire, CB21 6GH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Centralised Orphan - Designation EMA/OD/111/12 (2012)8194 of 08/11/2012